Ads
related to: food and drug administration, bristol-myers- Contact Us
Call + Email
24/7 Live Chat
- Verify: FDA Registration
Free Tool To Verify That Your US
FDA Registration Is Currently Valid
- Contact Us
Search results
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 1 day agoAt the midpoints, earnings would climb almost 17% as sales rise almost 3%. Pfizer Stock And Recent...
US FDA mandates label updates on CAR-T cancer therapies
Reuters· 22 hours agoThe U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology...
Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
The Wall Street Journal· 1 day agoLate last year, Bristol Myers Squibb also announced its entry into the field, buying Karuna...
FDA requires changes to CAR-T cell therapy boxed warning (NYSE:BMY)
Seeking Alpha· 10 hours agoThe FDA has mandated updates to safety information for CAR-T cell therapies due to a severe risk of...
Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
Investor's Business Daily· 4 days agoBristol Myers Squibb bought Karuna for $14 billion, and AbbVie is buying Cerevel for $8.7 billion....
Roche reports survival data for new dual-acting lymphoma drug
BioPharma Dive via Yahoo Finance· 4 days agoColumvi and Epkinly were both approved in 2023 and posted sales of $65 million and $17...
Neumora Therapeutics shares fall after rabbits dosed with schizophrenia drug have convulsions - The...
The Boston Globe· 4 days agoShares of Neumora Therapeutics fell more than 15 percent Monday morning after the Watertown biotech...
These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
InvestorPlace· 2 hours agoSmall-cap stocks tend to outperform their larger brethren over time. Inflation was moderating and...
J&J sees mixed performance from new multiple myeloma drugs
BioPharma Dive via Yahoo Finance· 3 days agoTecvayli sales, which J&J broke out for the first time, surpassed Wall Street forecasts and offset...